EMEA-001428-PIP03-15-M01

Key facts

Active substance
Esketamine (hydrochloride)
Therapeutic area
Psychiatry
Decision number
P/0238/2019
PIP number
EMEA-001428-PIP03-15-M01
Pharmaceutical form(s)
Nasal spray, suspension
Condition(s) / indication(s)
Treatment of major depressive disorder
Route(s) of administration
Intranasal use
Contact for public enquiries
Janssen-Cilag International NV

Tel. +32 473112810
E-mail: cmaria@its.jnj.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating